UNOFFICIAL COPY 24 RS BR 231
Page 1 of 8
XXXX 1/16/2024 2:37 PM Jacketed
AN ACT relating to the practice of pharmacy. 1
Be it enacted by the General Assembly of the Commonwealth of Kentucky: 2
Section 1. KRS 315.010 is amended to read as follows: 3
As used in this chapter, unless the context requires otherwise: 4
(1) "Administer" means the direct application of a drug to a patient or research subject 5
by injection, inhalation, or ingestion, whether topically or by any other means; 6
(2) "Administrative activities of a pharmacy" means the following functions performed 7
by a pharmacy adhering to all local, state, and federal patient privacy laws: 8
(a) Investigating and researching a patient's insurance benefits and updating the 9
patient profile regarding insurance coverage; 10
(b) Billing and collections activities, including: 11
1. Contacting patients for copayments and coinsurance payments; and 12
2. Communicating with insurance companies; 13
(c) Performing patient financial assistance activities and updating patient records 14
accordingly; 15
(d) Opening faxes and accessing electronic prescriptions for the purposes of 16
setting up patient demographic and insurance profiles, excluding height, 17
weight, and allergy information, so long as the activity does not involve the 18
entering of a prescription order into the dispensing or medication management 19
system; 20
(e) Initiating insurance prior authorizations for submission to the licensed 21
pharmacy, including communications with the prescribing physician to 22
collect, record, and transmit information to insurance companies, so long as 23
the activity does not include the authorization or receipt of new or refill 24
prescription orders; 25
(f) Answering and transferring telephone calls, whether or not such calls require 26
accessing a patient record, so long as the call does not involve the 27 UNOFFICIAL COPY 24 RS BR 231
Page 2 of 8
XXXX 1/16/2024 2:37 PM Jacketed
interpretation, evaluation, or implementation of a drug order; and 1
(g) Communicating with patients via telephone or electronically regarding refill 2
reminders, so long as the communication does not involve the interpretation, 3
evaluation, or implementation of a drug order and a pharmacist is readily 4
available for patient consultation; 5
(3) "Association" means the Kentucky Pharmacists Association; 6
(4) "Board" means the Kentucky Board of Pharmacy; 7
(5) "Collaborative care agreement" means a written agreement between a pharmacist or 8
pharmacists and a practitioner or practitioners that outlines a plan of cooperative 9
management of patients' drug-related health care needs where: 10
(a) Patients' drug-related health care needs fall within the practitioner's or 11
practitioners' statutory scope of practice; 12
(b) Patients are referred by the practitioner or practitioners to the pharmacist or 13
pharmacists; and 14
(c) The agreement: 15
1. Identifies the practitioner or practitioners and the pharmacist or 16
pharmacists who are parties to the agreement; 17
2. Specifies the drug-related regimen to be provided, and how drug therapy 18
is to be monitored; and 19
3. Stipulates the conditions for initiating, continuing, or discontinuing drug 20
therapy and conditions which warrant modifications to dose, dosage 21
regimen, dosage form, or route of administration; 22
(6) "Compound" or "compounding" means the preparation or labeling of a drug 23
pursuant to or in anticipation of a valid prescription drug order, including but not 24
limited to packaging, intravenous admixture, or manual combination of drug 25
ingredients. "Compounding," as used in this chapter, shall not preclude simple 26
reconstitution, mixing, or modification of drug products prior to administration by 27 UNOFFICIAL COPY 24 RS BR 231
Page 3 of 8
XXXX 1/16/2024 2:37 PM Jacketed
nonpharmacists; 1
(7) "Confidential information" means information which is accessed or maintained by a 2
pharmacist in a patient's record, or communicated to a patient as part of patient 3
counseling, whether it is preserved on paper, microfilm, magnetic media, electronic 4
media, or any other form; 5
(8) "Continuing education unit" means ten (10) contact hours of board approved 6
continuing pharmacy education. A "contact hour" means fifty (50) continuous 7
minutes without a break period; 8
(9) "Dispense" or "dispensing" means to deliver one (1) or more doses of a prescription 9
drug in a suitable container, appropriately labeled for subsequent administration to 10
or use by a patient or other individual entitled to receive the prescription drug; 11
(10) "Drug" means any of the following: 12
(a) Articles recognized as drugs or drug products in any official compendium or 13
supplement thereto; 14
(b) Articles, other than food, intended to affect the structure or function of the 15
body of man or other animals; 16
(c) Articles, including radioactive substances, intended for use in the diagnosis, 17
cure, mitigation, treatment or prevention of disease in man or other animals; 18
or 19
(d) Articles intended for use as a component of any articles specified in 20
paragraphs (a) to (c) of this subsection; 21
(11) "Drug regimen review" means retrospective, concurrent, and prospective review by 22
a pharmacist of a patient's drug-related history, including but not limited to the 23
following areas: 24
(a) Evaluation of prescription drug orders and patient records for: 25
1. Known allergies; 26
2. Rational therapy contraindications; 27 UNOFFICIAL COPY 24 RS BR 231
Page 4 of 8
XXXX 1/16/2024 2:37 PM Jacketed
3. Appropriate dose and route of administration; 1
4. Appropriate directions for use; or 2
5. Duplicative therapies; 3
(b) Evaluation of prescription drug orders and patient records for drug-drug, 4
drug-food, drug-disease, and drug-clinical laboratory interactions; 5
(c) Evaluation of prescription drug orders and patient records for adverse drug 6
reactions; or 7
(d) Evaluation of prescription drug orders and patient records for proper 8
utilization and optimal therapeutic outcomes; 9
(12) "Immediate supervision" means under the physical and visual supervision of a 10
pharmacist; 11
(13) "Manufacturer" or "virtual manufacturer" of a product means: 12
(a) A person that holds an application approved under 21 U.S.C. sec. 355 or a 13
license issued under 42 U.S.C. sec. 262 for such product, or if such product is 14
not the subject of an approved application or license, the person who 15
manufactured the product; 16
(b) A co-licensed partner of the person described in paragraph (a) of this 17
subsection that obtains the product directly from a person described in this 18
paragraph or paragraph (a) of this subsection; 19
(c) An affiliate of a person described in paragraph (a) or (b) of this subsection 20
who receives the product directly from a person described in this paragraph or 21
in paragraph (a) or (b) of this subsection; or 22
(d) Any person, except a pharmacist compounding in the normal course of 23
professional practice; 24
(14) "Medical order" means a lawful order of a specifically identified practitioner for a 25
specifically identified patient for the patient's health care needs. "Medical order" 26
may or may not include a prescription drug order; 27 UNOFFICIAL COPY 24 RS BR 231
Page 5 of 8
XXXX 1/16/2024 2:37 PM Jacketed
(15) "Nonprescription drugs" means nonnarcotic medicines or drugs which may be sold 1
without a prescription and are prepackaged and labeled for use by the consumer in 2
accordance with the requirements of the statutes and regulations of this state and the 3
federal government; 4
(16) "Outsourcing facility" means a facility at one (1) geographic location or address 5
that: 6
(a) Is engaged in the compounding of human sterile drugs without a patient-7
specific prescription; 8
(b) Has registered as an outsourcing facility with the secretary of the United 9
States Department of Health and Human Services, Food and Drug 10
Administration; and 11
(c) Complies with all applicable state and federal requirements; 12
(17) "Pharmacist" means a natural person licensed by this state to engage in the practice 13
of the profession of pharmacy; 14
(18) "Pharmacist intern" means a natural person who is: 15
(a) Currently certified by the board to engage in the practice of pharmacy under 16
the direction of a licensed pharmacist and who satisfactorily progresses 17
toward meeting the requirements for licensure as a pharmacist; 18
(b) A graduate of an approved college or school of pharmacy or a graduate who 19
has established educational equivalency by obtaining a Foreign Pharmacy 20
Graduate Examination Committee (FPGEC) certificate, who is currently 21
licensed by the board for the purpose of obtaining practical experience as a 22
requirement for licensure as a pharmacist; 23
(c) A qualified applicant awaiting examination for licensure as a pharmacist or 24
the results of an examination for licensure as a pharmacist; or 25
(d) An individual participating in a residency or fellowship program approved by 26
the board for internship credit; 27 UNOFFICIAL COPY 24 RS BR 231
Page 6 of 8
XXXX 1/16/2024 2:37 PM Jacketed
(19) "Pharmacy" means every place where: 1
(a) Drugs are dispensed under the direction of a pharmacist; 2
(b) Prescription drug orders are compounded under the direction of a pharmacist; 3
or 4
(c) A registered pharmacist maintains patient records and other information for 5
the purpose of engaging in the practice of pharmacy, whether or not 6
prescription drug orders are being dispensed; 7
(20) "Pharmacy-related primary care" means the pharmacists' activities in patient 8
education, health promotion, and assistance in the selection and use of over-the-9
counter drugs and appliances for the treatment of common diseases and injuries, as 10
well as those other activities falling within their statutory scope of practice; 11
(21) "Pharmacy technician" means a natural person who works under the immediate 12
supervision, or general supervision if otherwise provided for by statute or 13
administrative regulation, of a pharmacist for the purpose of assisting a pharmacist 14
with the practice of pharmacy; 15
(22) "Practice of pharmacy" means interpretation, evaluation, and implementation of 16
medical orders and prescription drug orders; responsibility for dispensing 17
prescription drug orders, including radioactive substances; participation in drug and 18
drug-related device selection; administration of medications or biologics in the 19
course of dispensing or maintaining a prescription drug order; the administration of 20
adult immunizations pursuant to prescriber-approved protocols; the administration 21
of immunizations to individuals three[nine] (3[9]) to seventeen (17) years of age 22
pursuant to prescriber-approved protocols with the consent of a parent or guardian; 23
the administration of immunizations to a child as defined in KRS 214.032, pursuant 24
to protocols as authorized by KRS 315.500; drug evaluation, utilization, or regimen 25
review; maintenance of patient pharmacy records; and provision of patient 26
counseling and those professional acts, professional decisions, or professional 27 UNOFFICIAL COPY 24 RS BR 231
Page 7 of 8
XXXX 1/16/2024 2:37 PM Jacketed
services necessary to maintain and manage all areas of a patient's pharmacy-related 1
care, including pharmacy-related primary care as defined in this section; 2
(23) "Practitioner" has the same meaning given in KRS 217.015(35); 3
(24) "Prescription drug" means a drug which: 4
(a) Under federal law is required to be labeled with either of the following 5
statements: 6
1. "Caution: Federal law prohibits dispensing without prescription"; 7
2. "Caution: Federal law restricts this drug to use by, or on the order of, a 8
licensed veterinarian"; 9
3. "Rx Only"; or 10
4. "Rx"; or 11
(b) Is required by any applicable federal or state law or administrative regulation 12
to be dispensed only pursuant to a prescription drug order or is restricted to 13
use by practitioners; 14
(25) "Prescription drug order" means an original or new order from a practitioner for 15
drugs, drug-related devices or treatment for a human or animal, including orders 16
issued through collaborative care agreements or protocols authorized by the board. 17
Lawful prescriptions result from a valid practitioner-patient relationship, are 18
intended to address a legitimate medical need, and fall within the prescribing 19
practitioner's scope of professional practice; 20
(26) "Society" means the Kentucky Society of Health-Systems Pharmacists; 21
(27) "Supervision" means the presence of a pharmacist on the premises to which a 22
pharmacy permit is issued, who is responsible, in whole or in part, for the 23
professional activities occurring in the pharmacy; and 24
(28) "Wholesaler" means any person who legally buys drugs for resale or distribution to 25
persons other than patients or consumers. 26
Section 2. KRS 315.205 is amended to read as follows: 27 UNOFFICIAL COPY 24 RS BR 231
Page 8 of 8
XXXX 1/16/2024 2:37 PM Jacketed
Upon the request of an individual or his or her parent or guardian, a pharmacist who 1
administers an immunization to an individual who is three[nine] (3[9]) to seventeen (17) 2
years of age, as authorized in KRS 315.010[(22)], shall provide notification of the 3
immunization to the individual's primary care provider. 4